| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 2380013-17-0 | Nampt-IN-5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | | (Rac)-BMS-816336 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 66521-38-8 | Melatonin D4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 848133-17-5 | HKI-357 |
≥98% | | 询价 |
| 5 | 942047-63-4 | Meloxicam D4 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 1597440-03-3 | (Rac)-BRD0705 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 1049741-03-8 | SPD304 diHCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 147776-06-5 | L-161982 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 472-70-8 | β-Cryptoxanthin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 1154518-97-4 | Sootepin D |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 827306-88-7 | Acetyl Tetrapeptide-3 |
≥98% | | 询价 |
| 12 | 400775-35-1 | Bis-propargyl-PEG7 |
≥98% | | 询价 |
| 13 | 473268-46-1 | ADDA 5 hydrochloride |
≥98% | | 询价 |
| 14 | 7125-70-4 | Amiquinsin hydrochloride |
≥98% | | 询价 |
| 15 | 151165-96-7 | S-8921 |
≥98% | | 询价 |
| 16 | 5868-06-4 | Fentonium bromide |
≥98% | | 询价 |
| 17 | 89617-02-7 | STA 2 |
≥98% | | 询价 |
| 18 | 1818294-44-8 | Amino-PEG9-t-butyl ester |
≥98% | | 询价 |
| 19 | 499-67-2 | Proparacaine |
≥98% | | 询价 |
| 20 | 110072-15-6 | Tosagestin |
≥98% | | 询价 |
| 21 | 90996-54-6 | Rhizoxin |
≥98% | | 询价 |
| 22 | 152-75-0 | Red 21 |
≥98% | | 询价 |
| 23 | 67375-30-8 | alpha-Cypermethrin |
≥98% | | 询价 |
| 24 | 26599-17-7 | Thiarabine(OSI-7836) |
≥98% | | 询价 |
| 25 | 5307-59-5 | Robustic acid |
≥98% | | 询价 |
| 26 | 188257-69-4 | SB234551 |
≥98% | | 询价 |
| 27 | 958646-17-8 | Epofolate |
≥98% | | 询价 |
| 28 | 129192-62-7 | Locustamyotropin |
≥98% | | 询价 |
| 29 | 863-76-3 | Amyrin acetate |
≥98% | | 询价 |
| 30 | 57653-26-6 | Fenobam |
≥98% | | 询价 |
| 31 | 1807530-11-5 | Propargyl-PEG4-methylamine |
≥98% | | 询价 |
| 32 | 1428629-70-2 | PROPARGYL-PEG4-NHS ESTER |
≥98% | | 询价 |
| 33 | 207732-11-4 | BB-78485 |
≥98% | | 询价 |
| 34 | 74513-77-2 | Ro 363 |
≥98% | | 询价 |
| 35 | 852315-00-5 | CB1 inverse agonist 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 36839-55-1 | 1,2-Bis(2-iodoethoxy)ethane |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 1356479-78-1 | CYP11B2-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 1159588-21-2 | (Z)-Pitavastatin calcium |
≥98% | | 询价 |
| 39 | 6402-36-4 | Traumatic Acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | 1373346-85-0 | M4284 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 14432-09-8 | 1-Deazaadenosine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 847553-89-3 | SHA 68 |
≥98% | | 询价 |
| 43 | | Aβ42-IN-1 free base |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 2185795-67-7 | Lenalidomide-PEG1-azide |
≥98% | | 询价 |
| 45 | | (S,R,S)-AHPC-Me-C7 ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 2402772-45-4 | ATX inhibitor 5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 2346614-58-0 | IDO1-IN-2 |
≥98% | | 询价 |
| 48 | 2376774-73-9 | Mcl-1 inhibitor 3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 2093388-52-2 | Thalidomide-NH-C4-NH-Boc |
≥98% | | 询价 |
| 50 | 2380028-10-2 | RIP2 kinase inhibitor 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 1515888-53-5 | UCB-9260 |
≥98% | | 询价 |
| 52 | 2408842-51-1 | WDR5-IN-1 |
≥98% | | 询价 |
| 53 | 2133360-04-8 | Pomalidomide-PEG1-azide |
≥98% | | 询价 |
| 54 | 2337386-47-5 | PARP/PI3K-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 2304549-73-1 | GFB-8438 |
≥98% | | 询价 |
| 56 | 1252765-13-1 | JNJ-42226314 |
≥98% | | 询价 |
| 57 | 1312534-69-2 | Syk-IN-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | 2222264-64-2 | GLPG-3221 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | 2375107-27-8 | Mutated EGFR-IN-3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 2287259-07-6 | EP4 Receptor Antagonist 1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
m.cnreagent.com